The Study
Statins: Cardiovascular Risk Reduction in Percutaneous Coronary Intervention—Basic and Clinical Evidence of Hyperacute Use of Statins
This study is like a teacher's lecture that explains what other scientists have found. It doesn't do its own experiment but tells you about experiments others did. So, it helps you understand ideas, but you can't say 'this study proves' something true.
Analysis score
Maximum 5 for a narrative review.
Where the score came from
Giving a high dose of atorvastatin just before a heart procedure like stent placement may help protect the heart muscle, especially if the patient hasn’t been on statins before.
Where does this study sit?
Systematic Reviews & Meta-analyses
Max 100Randomized Trials
Max 90Cohort Studies
Max 72Case-Control
Max 58Cross-Sectional
Max 44Case Reports & Series
Max 30Expert Opinion
Max 51 / 100
Quality score
The highest quality evidence. These studies systematically search, appraise, and synthesize results from multiple individual studies, providing the most reliable summary of current knowledge.
Key takeaways
Summary
Based on the study abstract and findings.
- 1Yes, especially for people not already on statins or those with high inflammation — the protection is meaningful even if overall death or heart attack rates didn’t change in all groups.
- 2In patients not on statins, 80 mg before PCI cut heart damage from 15.8% to 9.5%.
- 3In heart attack patients, it improved blood flow signs like ST-segment recovery (61.8% vs 50.6%) and better blush grade (2.2 vs 1.9).
Score breakdown, methodology, conflicts of interest, evidence analysis & raw study data
Publication
Journal
International Journal of Hypertension
Year
2011
Authors
E. Morales-Villegas, G. Di Sciascio, C. Briguori
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.